VAT rate for commodity code 3004 in the EU — Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale

Commodity code 3004 (Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale) carries rates from 0% to 13.5% across the 12 EU member states that report a rate for it. The full table is below, and the same data is available as JSON.

CountryRateClassCategory
Belgium6%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
Belgium6%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
Estonia9%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
Greece6%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
Greece13%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
Finland13.5%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
France10%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
France2.1%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
Croatia5%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
Italy10%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
Luxembourg3%ReducedFoodstuffs (including beverages but excluding alcoholic beverages) for human and animal co
Malta0%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
Portugal6%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
Romania11%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and
Slovenia9.5%ReducedPharmaceutical products of a kind normally used for health care, prevention of illness and

What the member states say

Belgium
Royal Decree N° 20, Table A, category XVII The reduced rates only applies to: -medicinal products registered as medicines/medicinal product according to the Belgian law: 3002 1200, 3002 1900, 3002 1300, 3002 1400, 3002 1500, 3002 2000, 3002 3000, 3006 3000, 3006 7000, 3824 9958, 3002 9030, 3002 9050, 3002 9090, 3004, 3006 6000
Belgium
Royal Decree N° 20, Table A, category XVII The reduced rate only applies to: - products offered for sale for oral consumption by humans, excluding beverages: 3002 9050, 3004, 3006 6000 - bone cements containing antibiotics having an action accessory to that of the device: 3006 4000 - sterile viscoelastic substances strictly intended for human or veterinary medical or surgical use: 3304 99
Estonia
This reduced rate applies only to medicinal products within the meaning of Medicinal Products Act.
Greece
Reduced rate applies only on medicaments for human medicine of tariff heading 3003 and 3004 and vaccines and immunological products for human medicine of tariff heading 3002
Finland
Restricted to medicines in the meaning of The Medicines Act. Including herbal medicinal products and homeopathic preparations in so far they, according to the registration due to The Med. Act may be sold only at pharmacies. Also including clinical foodstuffs as well as basic creams and ointments in so far they are eligible for reimbursement in accordance with the The Health Insurance Act. Female s
France
For non reimbursed pharmaceutical products (article 278 quater of the general tax code)
France
For reimbursed pharmaceutical products (article 281 octies of the general tax code)
Croatia
Applies to medicines which have the approval of the competent authority for medicines and medical products.